Difference between revisions of "Eli Lilly and Company"

From Powerbase
Jump to: navigation, search
m (→‎Board of Directors)
(→‎Board of Directors)
Line 6: Line 6:
 
* [[Sidney Taurel]] - Chairman & CEO. Taurel's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4148&Group=2 Sidney Taurel] Accessed 31st January 2008</ref> describes how he first joined Eli Lilly in 1971 and took up his current positions of CEO in 1998 and Chairman in 1999. He is a member of the boards of [[IBM Corporation]], [[McGraw-Hill Companies Inc.]], the [[RCA Tennis Championships]], is a member of the board of overseers of the [[Columbia Business School]], a trustee at [[Indianapolis Museum of Art]], a member of The [[Business Council]] and The [[Business Roundtable]]. He is also on the [[Advisory Committee for Trade Policy and Negotiations]] and is an officer of the [[French Legion of Honor]]. Taurel was previously president and a member of the executive committee of the board of directors for the [[Pharmaceutical Research and Manufacturers of America]] (PhRMA)
 
* [[Sidney Taurel]] - Chairman & CEO. Taurel's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4148&Group=2 Sidney Taurel] Accessed 31st January 2008</ref> describes how he first joined Eli Lilly in 1971 and took up his current positions of CEO in 1998 and Chairman in 1999. He is a member of the boards of [[IBM Corporation]], [[McGraw-Hill Companies Inc.]], the [[RCA Tennis Championships]], is a member of the board of overseers of the [[Columbia Business School]], a trustee at [[Indianapolis Museum of Art]], a member of The [[Business Council]] and The [[Business Roundtable]]. He is also on the [[Advisory Committee for Trade Policy and Negotiations]] and is an officer of the [[French Legion of Honor]]. Taurel was previously president and a member of the executive committee of the board of directors for the [[Pharmaceutical Research and Manufacturers of America]] (PhRMA)
  
−
* [[Winfried Bischoff]] - Bischoff's biography<ref>Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4454&Group=2 Winifried Bischoff] Accessed 31st January 2008</ref> reports that he joined Eli Lilly in 2000. Bischoff is also chairman of [[Citi Europe]], on the management committee of [[Citi Inc.]], a nonexecutive director of The [[McGraw-Hill Companies]] and [[Land Securities plc]], a member of the [[City Promotion Panel]] and a member of the [[Council for Industry and Higher Education]]. HIs previous involvements include serving [[J Henry Schroder & Co. Limited]], [[Schroders Asia Limited]] and [[Schroders plc]]. He has also previously served on the boards of [[Siemens Holdings plc]], [[Cable and Wireless plc]] and [[IFIL Finanziaria di Partecipazioni SPA]], Italy.  
+
* [[Winfried Bischoff]] - Bischoff's biography<ref>Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4454&Group=2 Winifried Bischoff] Accessed 31st January 2008</ref> reports that he joined Eli Lilly in 2000. Bischoff is also chairman of [[Citi Europe]], on the management committee of [[Citi Inc.]], a nonexecutive director of The [[McGraw-Hill Companies]] and [[Land Securities plc]], a member of the [[City Promotion Panel]] and a member of the [[Council for Industry and Higher Education]]. His previous involvements include serving [[J Henry Schroder & Co. Limited]], [[Schroders Asia Limited]] and [[Schroders plc]]. He has also previously served on the boards of [[Siemens Holdings plc]], [[Cable and Wireless plc]] and [[IFIL Finanziaria di Partecipazioni SPA]], Italy.  
 
           
 
           
−
* [[J. Michael Cook]] - Cook's biography<ref>Eli Lilly Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=7346&Group=2 J Michael Cook] Accessed 31st January 2008</ref> reports that he joined Eli Lilly in 2005. Cook also serves as a member of the Advisory Council of the [[Public Company Accounting Oversight Board]], is a trustee of the [[Scripps Research Institute]], is on the boards of [[Comcast Corp.]], [[International Flavors & Fragrances Inc.]], [[AT&T Corp.]], [[Fidelity Group of Mutual Funds]], [[HCA]] – The Healthcare Co., [[Northrop Grumman Corp.]] and [[Rockwell International]]. He is chair of the audit committees for [[Comcast]] and [[International Flavors & Fragrances Inc.]]. He also serves as chairman of the [[Accountability Advisory Council to the Comptroller General of the United States]], is a member of the [[National Association of Corporate Directors Blue Ribbon Panel on Corporate Governance]] and was named the 62nd member of the [[Accounting Hall of Fame]] in 1999. Cooks previous involvements include serving as chairman and chief executive officer of [[Deloitte and Touche]] LLP and as past president of the [[Institute of Outstanding Directors]]. Cook is also reported to have 'written and spoken extensively on international accounting standards, business globalization, auditor independence, corporate governance, gender equality in the workplace, tort and securities law reform, and he has often testified before Congress on professional issues'.  
+
* [[J. Michael Cook]] - Cook's biography<ref>Eli Lilly Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=7346&Group=2 J Michael Cook] Accessed 31st January 2008</ref> reports that he joined Eli Lilly in 2005. Cook also serves as a member of the Advisory Council of the [[Public Company Accounting Oversight Board]], is a trustee of the [[Scripps Research Institute]], is on the boards of [[Comcast Corp.]], [[International Flavors & Fragrances Inc.]], [[AT&T Corp.]], [[Fidelity Group of Mutual Funds]], [[HCA]] – The Healthcare Co., [[Northrop Grumman Corp.]] and [[Rockwell International]]. He is chair of the audit committees for [[Comcast]] and [[International Flavors & Fragrances Inc.]]. He also serves as chairman of the [[Accountability Advisory Council]] to the [[Comptroller General of the United States]], is a member of the [[National Association of Corporate Directors Blue Ribbon Panel on Corporate Governance]] and was named the 62nd member of the [[Accounting Hall of Fame]] in 1999. Cooks previous involvements include serving as chairman and chief executive officer of [[Deloitte and Touche]] LLP and as past president of the [[Institute of Outstanding Directors]]. Cook is also reported to have 'written and spoken extensively on international accounting standards, business globalization, auditor independence, corporate governance, gender equality in the workplace, tort and securities law reform, and he has often testified before Congress on professional issues'.  
−
* [[Martin S Feldstein]] -
+
* [[Martin S Feldstein]] - Feldstein's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4151&Group=2 Martin S Feldstein] Accessed 31st January 2008</ref> reports that he joined Eli Lilly in 2002. Feldstein is also the George F. Baker Professor of Economics at [[Harvard University]], President and CEO of the [[National Bureau of Economic Research]], a member of the [[American Philosophical Society]], the Institute of Medicare of the [[National Academy of Sciences]], and is a fellow of the [[British Academy]], the [[Econometric Society]] and the [[National Association for Business Economics]]. Feldstein is a member of the executive committee of the [[Trilateral Commission]], a director of the [[Council on Foreign Relations]] and a member of the [[American Academy of Arts and Sciences]]. Feldstein is also a director of [[American International Group]] and is reported to be an economic advisor to several businesses in the United States and abroad whilst also contributing regularly to The [[Wall Street Journal]]. His previous involvements include serving as chairman of the [[Council of Economic Advisers]] and as President Ronald Reagan's chief economic advisor. He also previously served as a fellow at [[Nuffield College]] (1964-67), was a lecturer in public finance for [[Oxford University]] and served as an assistant professor (in 1967), associate professor (in 1968) and full professor (in 1969) at Harvard University.
−
* [[George M C Fisher]]  
+
 
−
* [[J Erik Fyrwald]]
+
* [[George M C Fisher]] - Fisher's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4455&Group=2 George M C Fisher] Accessed 31st January 2008</ref> reported that he is also a Senior Advisor for [[Kohlberg Kravis Roberts and Company]] and Presiding Director of [[General Motors Corporation]]. He is a fellow of the [[American Academy of Arts and Sciences]] and of the [[International Academy of Astronautics]]. Fisher's previous involvements include serving as chairman & CEO for [[Motorola Inc.]] and the [[Eastman Kodak Company]]. He worked for ten years in research and development at [[Bell Telephone Laboratories]], served as Chairman of [[PanAmSat Corporation]] and was on the boards of [[AT&T]], [[American Express Company]], [[Comcast Corporation]], [[Delta Air Lines Inc.]], [[Eastman Kodak Company]], [[Hughes Electronics Corporation]], [[Motorola, Inc.]], [[Minnesota Mining and Manufacturing]], [[Brown University]] and The [[National Urban League Inc.]] Fisher also served as chairman of the [[National Academy of Engineering]] (2000-2004), is a former member of the boards of the [[University of Illinois Foundation]] (1997-1999) and the [[U.S.-China Business Council]] (1997-1999), former chairman the [[Council on Competitiveness]] (1991-1993), former member of the [[World Wildlife Fund National Council]] and [[Trustee Emeritus of George Eastman House]]. He also previously served as Vice Chairman for The [[Business Council]] (1997-1999), as Chairman of the [[Industry Policy Advisory Committee]] (IPAC) and as member of the President's [[Advisory Council for Trade Policy and Negotiations]] (ACTPN) (1993-2002). It is also reported that Fisher 'has been active in U.S./International trade issues through advisory groups to the [[U.S. Trade Representative]] and the [[U.S. Secretary of Commerce]]'.
−
* [[Alfred G Gilman]]
+
−
* [[Karen N Horn]]
+
* [[J Erik Fyrwald]] - Fyrwald's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=9343&Group=2 J Erik Fyrwald] Accessed 31st January 2008</ref> describes how he is currently also Group Vice President of [[DuPont]] Agriculture & Nutrition (since 2003), having served [[DuPont]] in a variety of areas since he joined them in 1981. Fyrwald also serves on the boards of [[CropLife International]] President's Advisory Group, [[Des Moines Art Center]], [[Greater Des Moines Partnership]] (Public and Private Collaboration) and The [[Solae Company]].
−
* [[John C Lechleiter]]  
+
−
* [[Ellen R Marram]]    
+
* [[Alfred G Gilman]] - Gilman's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4456&Group=2 Alfred G Gilman] Accessed 31st January 2008</ref> reports that he joined Eli Lilly in 1995. Gilman is also Executive Vice President for academic affairs and provost at the [[University of Texas]] Southwestern Medical Center at Dallas, where he also serves as regental professor of pharmacology and as Dean of Southwestern Medical School. He is a member of the board of directors of [[Regeneron Pharmaceuticals Inc.]]. Gilman previously served ten years with the [[University of Virginia]] in Charlottesville (commencing in 1971), where his positions included assistant, associate, and professor of pharmacology, and director of the medical scientist training program. He was also the editor of Goodman and Gilman's The <i>[[Pharmacological Basis of Therapeutics]]</i> from 1980–1990.
−
* [[Franklyn G Prendergast]]
+
 
−
* [[Kathi P Seifert]]
+
* [[Karen N Horn]] - Horn's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4458&Group=2 Karen N Horn] Accessed 31st January 2008</ref> reports that she joined Eli Lilly in 1987. Horn is also Senior Managing Director for the [[Brock Capital Group]] (since 2004), is a Director of [[T Rowe Price Mutual Funds]], The [[U.S. Russia Investment Fund]] (a presidential appointment), the [[Simon Property Group]] and [[Fannie Mae]]. Horn has also served on the President's [[Bipartisan Commission on Entitlements]]. Her previous involvements include serving as President for [[Private Client Services]], senior managing director and head of international private banking for [[Bankers Trust Company]], chairman and CEO of [[Bank One]], President of the [[Federal Reserve Bank of Cleveland]], Treasurer of the [[Bell Telephone Company]], Vice President of [[First National Bank]] of Boston, and between 1999 to 2003, as Managing Director of [[Marsh Inc.]] (a subsidiary of [[MMC]]).
 +
 
 +
* [[John C Lechleiter]] - President & CEO. Lechleiter's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=9191&Group=2 John C Lechleiter] Accessed 31st January 2008</ref> describes how he joined Eli Lilly in 1979 and served in a variety of positions (including the company's policy and strategy committee and as Vice President for development and regulatory affairs) before taking up the positions of CEO and President in 2008. Lechleiter is also a member of the [[American Chemical Society]], a member of the board of trustees of [[Xavier University]] (Cincinnati, Ohio), was appointed to the Visiting Committee of [[Harvard Business School]] and to the Health Policy and Management Executive Council of the [[Harvard School of Public Health]] (in 2004). He also serves as distinguished advisor of The [[Children's Museum of Indianapolis]], is a member of the board of directors and executive committee of [[Fairbanks Institute]], is on the board of [[Indianapolis Downtown Inc.]] and is a member of the [[United Way of Central Indiana]] board of directors.
 +
 
 +
* [[Ellen R Marram]] - Marram's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4459&Group=2 Ellen R Marram] accessed 31st January 2008</ref> reports that she is also President of The [[Barnegat Group]] LLC, Advisor to [[North Castle Partners]] L.L.C. (where she was formerly Managing Director 2000-2005), member of the Board of Directors of [[Ford Motor Company]], The [[New York Times]] Company and several other companies who's names are not disclosed. She is a Trustee of the [[Conference Board]] and also serves on the boards of The [[New York & Presbyterian Hospital]], [[Lincoln Center Theater]], [[Families and Work Institute]], and [[Citymeals-on-Wheels]]. Marram's previous involvements include serving as a member of the Board of Associates of [[Harvard Business School]], President and Chief Executive Officer of [[Tropicana]] and the [[Tropicana Beverage Group]] (1993-1998) and President and CEO of the [[Nabisco Biscuit Company]] (1987-1993). Between 1970 to 1986, she is reported to have 'held a series of marketing positions at [[Nabisco/Standard Brands]], [[Johnson & Johnson]] and [[Lever Brothers]].
 +
 
 +
* [[Franklyn G Prendergast]] - Prendergast's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4460&Group=2 Franklin G Prendergast] Accessed 31st January 2008</ref> reports that he joined Eli Lilly in 1995. Prendergast is a member of the [[American Chemical Society]], [[American Society for Photobiology]], [[American Association for the Advancement of Science]], [[Biophysical Society]], [[Sigma Xi]], [[American Society for Biochemistry and Molecular Biology]] and [[American Cancer Society]]. His biography describes how he has served the [[Mayo Medical School]] and the [[Mayo Foundation]] since joining the Mayo Medical School in 1975.
 +
 
 +
* [[Kathi P Seifert]] - Seifert's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4462&Group=2 Kathi P Seifert] accessed 31st January 2008</ref> reports that she joined Eli Lilly in 1995. Seifert is also Chairman of [[Pinnacle Perspectives]] LLC, a member the board of directors of [[Supervalu Inc.]], [[Revlon Consumer Products Corporation]], [[Lexmark International Inc.]], [[Appleton Papers Inc.]], the U.S. Fund for [[UNICEF]] and the [[Fox Cities Performing Arts Center]]. Seiferts previous involvements include serving [[Procter & Gamble]], [[Beatrice Foods]], [[Fort Howard Paper Company]] and as Executive Vice President for [[Kimberly-Clark Corporation]] (where she held a variety of positions between 1978-2004)
  
 
===Executive Management===
 
===Executive Management===

Revision as of 13:45, 31 January 2008

People

Board of Directors

Eli Lilly and Company list their Board of Directors for 2007 as[1]...

  • Alfred G Gilman - Gilman's biography[8] reports that he joined Eli Lilly in 1995. Gilman is also Executive Vice President for academic affairs and provost at the University of Texas Southwestern Medical Center at Dallas, where he also serves as regental professor of pharmacology and as Dean of Southwestern Medical School. He is a member of the board of directors of Regeneron Pharmaceuticals Inc.. Gilman previously served ten years with the University of Virginia in Charlottesville (commencing in 1971), where his positions included assistant, associate, and professor of pharmacology, and director of the medical scientist training program. He was also the editor of Goodman and Gilman's The Pharmacological Basis of Therapeutics from 1980–1990.

Executive Management

Eli Lilly and Company list their Executive Management for 2007 as comprising[14]...

Patient Groups

Eli Lilly and Company UK report their relationships with Patient Groups in 2006 as follows[15]...

In 2006, the Lilly Grants Committee has made the following grants:

Affiliations

Eli Lilly list some of their alliances with other organisations as follows[16]. The exact nature and timescales of the alliances are not disclosed.

Particia Martin, Executive Director of alliance management at Eli Lilly reported to Pharmaceutical Executive [17] that Lilly has been partnering for a long time and is involved in hundreds of alliances.

Eli Lilly provided generous support for the Expert Consensus Guideline Series: Treatment of Schizophrenia 1999 an initiative aiming at establishing uniform medication guidelines for schizophrenia[18]. It is reported that this was an initiative 'supported exclusively by 6 pharmaceutical companies: Eli Lilly and Company, Janssen Pharmaceutica Inc., Novartis Pharmaceuticals Corporation, Ortho-McNeil Pharmaceutical, Pfizer Inc. and Zeneca Pharmaceuticals' (now known as AstraZeneca). Michael Hogan and Laurie Flynn were also involved in this initiative.

References

  1. ↑ Elli Lilly and Company Director Profiles Accessed 27th December 2007
  2. ↑ Eli Lilly and Company Sidney Taurel Accessed 31st January 2008
  3. ↑ Eli Lilly and Company Winifried Bischoff Accessed 31st January 2008
  4. ↑ Eli Lilly Company J Michael Cook Accessed 31st January 2008
  5. ↑ Eli Lilly and Company Martin S Feldstein Accessed 31st January 2008
  6. ↑ Eli Lilly and Company George M C Fisher Accessed 31st January 2008
  7. ↑ Eli Lilly and Company J Erik Fyrwald Accessed 31st January 2008
  8. ↑ Eli Lilly and Company Alfred G Gilman Accessed 31st January 2008
  9. ↑ Eli Lilly and Company Karen N Horn Accessed 31st January 2008
  10. ↑ Eli Lilly and Company John C Lechleiter Accessed 31st January 2008
  11. ↑ Eli Lilly and Company Ellen R Marram accessed 31st January 2008
  12. ↑ Eli Lilly and Company Franklin G Prendergast Accessed 31st January 2008
  13. ↑ Eli Lilly and Company Kathi P Seifert accessed 31st January 2008
  14. ↑ Eli Lilly and Company Executive Management Accessed 27th December 2007
  15. ↑ Eli Lilly and Company Patient Group Relationships Accessed 31st December 2007
  16. ↑ Eli Lilly and Company Alliances Accessed 31st December 2007
  17. ↑ Pharmaceutical Executive Biotech and Pharma - Why Alliances FailAccessed 31st December 2007
  18. ↑ Weibert, S. The Genesis of President Bush’s New Freedom Commission on Mental Health Teenscreen Truth. Accessed 9th January 2008
Retrieved from "https://powerbase.info/index.php?title=Eli_Lilly_and_Company&oldid=44208"